SFRP2 and prostate carcinoma: More recently, an assay that evaluates the methylation of GSTP1, SFRP2, IGFBP3, IGFBP7, APC and PTGS2 genes to specifically identify individuals with a severe probability of developing prostate cancer has been proposed [101].